TC
SANA icon

Truvestments Capital’s Sana Biotechnology SANA Stock Holding History

Truvestments Capital’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-300
Closed -$864 – 1262
2026
Q1 		$864 Buy
+300
New +$1.18K ﹤0.01% 1066
2024
Q4 		– Sell
-50
Closed -$208 – 1052
2024
Q3 		$208 Buy
+50
New +$263 ﹤0.01% 901

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Truvestments Capital's SANA Position: Q2 2026 in Review

Truvestments Capital sold out of Sana Biotechnology (SANA) in Q2 2026, closing a stake of 300 shares — an estimated $864 sold.

Truvestments Capital first reported a position in SANA in Q3 2024 and held it in 2 quarters. The position peaked at $864 in Q1 2026. 212 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Truvestments Capital reported no remaining Sana Biotechnology position as of Q2 2026 after selling out during the quarter.
  • Truvestments Capital sold 300 Sana Biotechnology shares in Q2 2026, an estimated $864.
  • Truvestments Capital first reported a position in Sana Biotechnology in Q3 2024 and held it in 2 quarters.
  • Truvestments Capital's Sana Biotechnology position peaked at $864 in Q1 2026.
  • 212 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.